Status: current, Primitive. Date: 31-Jul 2008. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2742683013 | Eltrombopag olamine (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 2768571019 | Eltrombopag olamine | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Eltrombopag olamine | Is a | Thrombopoietin receptor agonist | true | Inferred relationship | Some | ||
| Eltrombopag olamine | Is a | Benzoic acid and/or benzoic acid derivative | true | Inferred relationship | Some | ||
| Eltrombopag olamine | Is a | Hydrazine and/or hydrazine derivative | true | Inferred relationship | Some | ||
| Eltrombopag olamine | Is a | Pyrazole and/or pyrazole derivative | true | Inferred relationship | Some | ||
| Eltrombopag olamine | Is modification of | Eltrombopag | true | Inferred relationship | Some | ||
| Eltrombopag olamine | Is a | Eltrombopag | false | Inferred relationship | Some | ||
| Eltrombopag olamine | Has disposition | Thrombopoietin receptor agonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Eltrombopag (as eltrombopag olamine) 25 mg oral tablet | Has precise active ingredient | True | Eltrombopag olamine | Inferred relationship | Some | 1 |
| Eltrombopag (as eltrombopag olamine) 12.5 mg oral tablet | Has precise active ingredient | True | Eltrombopag olamine | Inferred relationship | Some | 1 |
| Eltrombopag (as eltrombopag olamine) 50 mg oral tablet | Has precise active ingredient | True | Eltrombopag olamine | Inferred relationship | Some | 1 |
| Eltrombopag (as eltrombopag olamine) 75 mg oral tablet | Has precise active ingredient | True | Eltrombopag olamine | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR